Datamonitor, April 2010, Pages: 243
: Midostaurin: key historical events, 2002-2010
Table 76: Clinical development of midostaurin in acutemyeloidleukemia, 2010
Table 77: Sales forecast for midostaurin in cancer across the seven major markets
Datamonitor, Dec 2009, Pages: 174
development of PR1 peptide antigen, 2009
Table 60: Sales forecast for PR1 peptide antigen in acutemyeloidleukemia (AML) across the seven major markets, 2009-2018 ($m)
Table 61: Stimuvax - drug profile, 2009